Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Operating Cash Flow Growth TrendStable
Percentile Rank84
3Y CAGR+78.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+78.6%/yr
vs -36.2%/yr prior
Acceleration
+114.7pp
Accelerating
Percentile
P84
Within normal range
vs 3Y Ago
5.7x
Strong expansion
Streak
1 qtr
Consecutive declineStable
| Period | Value |
|---|---|
| Q3 2025 | 47.51% |
| Q2 2025 | 48.04% |
| Q1 2025 | -368.89% |
| Q4 2024 | 120.98% |
| Q3 2024 | -55.15% |
| Q2 2024 | 40.89% |
| Q1 2024 | -21.41% |
| Q4 2023 | 77.78% |
| Q3 2023 | -5.80% |
| Q2 2023 | -5.49% |
| Q1 2023 | 11.77% |
| Q4 2022 | 28.97% |
| Q3 2022 | 8.35% |
| Q2 2022 | 15.71% |
| Q1 2022 | -48.73% |
| Q4 2021 | -8.92% |
| Q3 2021 | -43.82% |
| Q2 2021 | 61.89% |
| Q1 2021 | -2.95% |
| Q4 2020 | 6.69% |
| Q3 2020 | -5.82% |
| Q2 2020 | 51.26% |
| Q1 2020 | -31.66% |
| Q4 2019 | 6.93% |
| Q3 2019 | -8.39% |
| Q2 2019 | 35.90% |
| Q1 2019 | -48.03% |
| Q4 2018 | 8.50% |
| Q3 2018 | -11.88% |
| Q2 2018 | 14.42% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |